Federal Register / Vol. 79, No. 8 / Monday, January 13, 2014 / Notices 2155 

7700 Arlington Boulevard, Suite 5101, 

Falls Church, VA 22042–5101, or call 

703–681–0039. 

SUPPLEMENTARY INFORMATION: 

Title; Associated Form; and OMB 

Number: Women, Infants and Children 

Overseas Participant Satisfaction 

Survey; OMB Control Number 0720– 

0046. 

Needs and Uses: The information 

collection requirement is necessary to 

obtain the participant’s satisfaction 

levels with the services provided by the 

WIC overseas staff and the overall 

program. The findings from the surveys 

will be used to determine the success of 

the WIC overseas program and if 

improvements are necessary. 

Affected Public: Individual or 

Households 

Annual Burden Hours: 37.5 

Number of Respondents: 150 

Responses per Respondent: 1 

Average Burden per Response: 15 

minutes 

Frequency: On occasion 

Respondents are individuals who are 

currently receiving WIC overseas 

services. The purpose of the WIC 

overseas survey is to assess the 

participant’s satisfaction level with the 

services provided by the WIC overseas 

staff and the overall program. The 

survey includes questions regarding site 

access, customer service, quality of 

health information and overall program 

satisfaction. The findings of these 

surveys will be used to determine the 

success of the WIC overseas program 

and if improvements are necessary. The 

WIC overseas program is a legislatively 

mandated program and it is anticipated 

that the program will continue 

indefinitely. As such, DoD is publishing 

this formal notice. 

Dated: January 8, 2014. 

Aaron Siegel, 

Alternate OSD Federal Register Liaison 

Officer, Department of Defense. 

[FR Doc. 2014–00361 Filed 1–10–14; 8:45 am] 

BILLING CODE 5001–06–P 

DEPARTMENT OF DEFENSE 

Office of the Secretary 

[Docket ID DoD–2014–HA–0004] 

Proposed Collection; Comment 

Request 

AGENCY: Office of the Assistant 

Secretary of Defense for Health Affairs, 

DoD. 

ACTION: Notice. 

SUMMARY: In compliance with Section 

3506(c)(2)(A) of the Paperwork 

Reduction Act of 1995, the Office of the 

Assistant Secretary of Defense for 

Health Affairs announces a proposed 

public information collection and seeks 

public comment on the provisions 

thereof. Comments are invited on: (a) 

Whether the proposed collection of 

information is necessary for the proper 

performance of the functions of the 

agency, including whether the 

information shall have practical utility; 

(b) the accuracy of the agency’s estimate 

of the burden of the proposed 

information collection; (c) ways to 

enhance the quality, utility, and clarity 

of the information to be collected; and 

(d) ways to minimize the burden of the 

information collection on respondents, 

including through the use of automated 

collection techniques or other forms of 

information technology. 

DATES: Consideration will be given to all 

comments received by March 14, 2014. 

ADDRESSES: You may submit comments, 

identified by docket number and title, 

by any of the following methods: 

• Federal eRulemaking Portal: http:// 

www.regulations.gov. Follow the 

instructions for submitting comments. 

• Mail: Federal Docket Management 

System Office, 4800 Mark Center Drive, 

East Tower, Suite 02G09, Alexandria, 

VA 22350–3100. 

Instructions: All submissions received 

must include the agency name, docket 

number and title for this Federal 

Register document. The general policy 

for comments and other submissions 

from members of the public is to make 

these submissions available for public 

viewing on the Internet at http://

www.regulations.gov as they are 

received without change, including any 

personal identifiers or contact 

information. 

Any associated form(s) for this 

collection may be located within this 

same electronic docket and downloaded 

for review/testing. Follow the 

instructions at http://

www.regulations.gov for submitting 

comments. Please submit comments on 

any given form identified by docket 

number, form number, and title. 

FOR FURTHER INFORMATION CONTACT: To 

request more information on this 

proposed information collection or to 

obtain a copy of the proposal and 

associated collection instruments, 

please write to the Defense Health 

Agency, Medical Benefits and 

Reimbursement Systems, 16401 East 

Centretech Parkway, ATTN: Elan Green, 

Aurora, CO 80011–9043, or call Defense 

Health Agency, Medical Benefits and 

Reimbursement Office, at (303) 676– 

3907. 

SUPPLEMENTARY INFORMATION: 

Title; Associated Form; and OMB 

Number: Application for TRICAREProvider Status: Corporation Services 

Provider; DD Form X644; OMB Number 

0720–0020. 

Needs and Uses: The information 

collection requirement is necessary to 

allow eligible providers to apply for 

Corporate Services Provider status 

under the TRICARE program. 

Affected Public: Business or other for 

profit; Not-for-profit institutions. 

Annual Burden Hours: 100. 

Number of Respondents: 300. 

Responses Per Respondent: 1. 

Average Burden per Response: 20 

minutes. 

Frequency: On occasion. 

On March 10, 1999, TRICARE 

Management Activity (TMA), formerly 

known as OCHAMPUS, published a 

final rule in the Federal Register (64 FR 

11765), creating a fourth class of 

TRICARE providers consisting of 

freestanding corporations and 

foundations that render principally 

professional ambulatory or in-home care 

and technical diagnostic procedures. 

Effective October 1, 2013, the TRICARE 

Management Activity is now the 

Defense Health Agency (DHA). The 

intent of the rule was not to create 

additional benefits that ordinarily 

would not be covered under TRICARE 

if provided by a more traditional 

healthcare delivery system, but rather to 

allow those services which would 

otherwise be allowed except for an 

individual provider’s affiliation with a 

freestanding corporate facility. The 

addition of the corporate class 

recognized the current range of 

providers within today’s health care 

delivery structure, and gave 

beneficiaries access to another segment 

of the health care delivery industry. 

Corporate services providers must be 

approved for Medicare payment, or 

when Medicare approval status is not 

required, be accredited by a qualified 

accreditation organization to gain 

provider authorization status under 

TRICARE. Corporate services providers 

must also enter into a participation 

agreement which will be sent out as part 

of the initial authorization process. The 

participation agreement will ensure that 

TRICARE-determined allowable 

payments, combined with the costshare/ 

copayment, deductible, and other health 

insurance amounts, will be accepted by 

the provider as payment in full. The 

application for TRICARE-Provider 

Status: Corporate Services Provider, will 

collect the necessary information to 

ensure that the conditions are met for 

authorization as a TRICARE corporate 

services provider: i.e., the provider (1) is 

a corporation or a foundation, but not a 


tkelley on DSK3SPTVN1PROD with NOTICES
2156 Federal Register / Vol. 79, No. 8 / Monday, January 13, 2014 / Notices 

professional corporation or professional 

association; (2) provides services and 

related supplies of a type rendered by 

TRICARE individual professional 

providers or diagnostic technical 

services; (3) is approved for Medicare 

payment or, when Medicare approval 

status is not required, is accredited by 

a qualified accreditation organization; 

and (4) has entered into a participation 

agreement approved by the Director, 

DHA or a designee. 

The collected information will be 

used by TRICARE contractors to process 

claims and verify authorized provider 

status. Verification involves collecting 

and reviewing copies of the provider’s 

licenses, certificates, accreditation 

documents, etc. If the criteria are met, 

the provider is granted TRICARE 

authorization status. The documentation 

and information are collected when: 

(1) A provider requests permission to 

become a TRICARE-authorized 

provider; (2) a claim is filed for care 

received from a provider who is not 

listed on the contractors’ computer 

listing of authorized providers; or (3) 

when a former TRICARE-authorized 

provider requests reinstatement. The 

contractors develop the forms used to 

gather information based on TRICARE 

conditions for participation listed 

above. Without the collection of this 

information, contractors cannot 

determine if the provider meets 

TRICARE-authorization requirements 

for corporate services providers. If the 

contractor is unable to verify that a 

provider meets these authorization 

requirements, the contractor may not 

reimburse either the provider or the 

beneficiary for the provider’s health care 

services. To reduce the reporting burden 

to a minimum, TRICARE has carefully 

selected the information requested from 

respondents. Only that information 

which has been deemed absolutely 

essential is being requested. If 

necessary, contractors may verify 

credentials with Medicare, JCAHO and 

other national organizations by 

telephone. TRICARE is also 

participating with Medicare in the 

development of a National Provider 

System which will eliminate 

duplication of provider certification 

data collection among Federal 

government agencies. TRICARE 

contractors are required to maintain a 

computer listing of all providers that 

have submitted the appropriate 

authorization information and 

documentation. To avoid duplicate 

inquires, the contractors must search the 

computer provider listing before 

requesting documentation from 

providers. Since the providers affected 

by this information collection generally 

have not previously been eligible to be 

authorized providers, TRICARE 

contractors will have no information on 

file. The providers will have to submit 

the information requested on the data 

collection form (Application for 

TRICARE-Providers Status: Corporate 

Services Provider) in order to obtain 

provider authorization status under 

TRICARE. The information will usually 

be collected from each respondent only 

once. It is estimated that there will be 

approximately 300 applicants per year. 

TRICARE will request the provider 

authorization documentation and 

information when the provider asks to 

become TRICARE-authorized or when a 

claim is filed for a new provider’s 

services. If after a provider has been 

authorized by a contractor, no claims 

are filed during two-year period of time, 

the provider’s information will be 

placed in the inactive file. To reactivate 

a file, the provider must verify that the 

information is still correct, or supply 

new or changed information. The total 

annual reporting burden is estimated to 

be approximately 100 hours 

(approximately 300 respondents with 20 

minutes to complete the form). 

Dated: January 7, 2014. 

Aaron Siegel, 

Alternate OSD Federal Register Liaison 

Officer, Department of Defense. 

[FR Doc. 2014–00296 Filed 1–10–14; 8:45 am] 

BILLING CODE 5001–06–P 

DEPARTMENT OF DEFENSE 

Department of the Army 

Notice of Availability for Exclusive, 

Non-Exclusive, or Partially-Exclusive 

Licensing of an Invention Concerning 

Anti-Filovirus Therapeutics 

AGENCY: Department of the Army, DoD. 

ACTION: Notice. 

SUMMARY: Announcement is made of the 

availability for licensing of the 

invention set forth in U.S. Provisional 

Patent Application Serial No. 61/

761,942, entitled ‘‘Anti-Filovirus 

Therapeutics,’’ filed on February 7, 

2013. The United States Government, as 

represented by the Secretary of the 

Army, has rights to this invention. 

ADDRESSES: Commander, U.S. Army 

Medical Research and Materiel 

Command, ATTN: Command Judge 

Advocate, MCMR–JA, 504 Scott Street, 

Fort Detrick, Frederick, MD 21702– 

5012. 

FOR FURTHER INFORMATION CONTACT: For 

patent issues, Ms. Elizabeth Arwine, 

Patent Attorney, (301) 619–7808. For 

licensing issues, Dr. Paul Mele, Office of 

Research and Technology Applications 

(ORTA), (301) 619–6664, both at telefax 

(301) 619–5034. 

SUPPLEMENTARY INFORMATION: The 

invention relates to an antisense 

oligonucleotide directed to a mRNA 

encoding a mammalian Niemann-Pick 

C1 (NPC1) receptor, and combinations 

thereof and compositions comprising 

such are provided. Also provided are 

methods of treating or reducing filovirus 

infection of a subject. 

Brenda S. Bowen, 

Army Federal Register Liaison Officer. 

[FR Doc. 2014–00290 Filed 1–10–14; 8:45 am] 

BILLING CODE 3710–08–P 

DEPARTMENT OF DEFENSE 

Department of the Army 

Notice of Availability for Exclusive, 

Non-Exclusive, or Partially-Exclusive 

Licensing of an Invention Concerning 

Imidazenil, or a Combination of 

Imidazenil and [+]-Huperzine A and/or 

[-]-Huperzine A for Protection Against 

and/or Treatment of Seizure/Status 

Epilepticus and Neuropathology 

Following Nerve Agent or 

Organophosphate Exposure, 

Compositions and Kits 

AGENCY: Department of the Army, DoD. 

ACTION: Notice. 

SUMMARY: Announcement is made of the 

availability for licensing of the 

invention set forth in U.S. Provisional 

Patent Application Serial No. 61/

726,753, entitled ‘‘Imidazenil, or a 

Combination of Imidazenil and [+]- 

Huperzine A and/or [-]-Huperzine A for 

Protection Against and/or Treatment of 

Seizure/Status Epilepticus and 

Neuropathology Following Nerve Agent 

or Organophosphate Exposure, 

Compositions and Kits,’’ filed on 

November 15, 2012. The United States 

Government, as represented by the 

Secretary of the Army, has rights to this 

invention. 

ADDRESSES: Commander, U.S. Army 

Medical Research and Materiel 

Command, ATTN: Command Judge 

Advocate, MCMR–JA, 504 Scott Street, 

Fort Detrick, Frederick, MD 21702– 

5012. 

FOR FURTHER INFORMATION CONTACT: For 

patent issues, Ms. Elizabeth Arwine, 

Patent Attorney, (301) 619–7808. For 

licensing issues, Dr. Paul Mele, Office of 

Research and Technology Applications 

(ORTA), (301) 619–6664, both at telefax 

(301) 619–5034. 


tkelley on DSK3SPTVN1PROD with NOTICES